BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12228132)

  • 1. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children.
    Whittle H; Jaffar S; Wansbrough M; Mendy M; Dumpis U; Collinson A; Hall A
    BMJ; 2002 Sep; 325(7364):569. PubMed ID: 12228132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
    BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose.
    Mendy M; Peterson I; Hossin S; Peto T; Jobarteh ML; Jeng-Barry A; Sidibeh M; Jatta A; Moore SE; Hall AJ; Whittle H
    PLoS One; 2013; 8(3):e58029. PubMed ID: 23533578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term protection against carriage of hepatitis B virus after infant vaccination.
    van der Sande MA; Waight P; Mendy M; Rayco-Solon P; Hutt P; Fulford T; Doherty C; McConkey SJ; Jeffries D; Hall AJ; Whittle HC
    J Infect Dis; 2006 Jun; 193(11):1528-35. PubMed ID: 16652281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia.
    Whittle HC; Inskip H; Hall AJ; Mendy M; Downes R; Hoare S
    Lancet; 1991 Mar; 337(8744):747-50. PubMed ID: 1672389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.
    Viviani S; Jack A; Hall AJ; Maine N; Mendy M; Montesano R; Whittle HC
    Vaccine; 1999 Aug; 17(23-24):2946-50. PubMed ID: 10462228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine induced protection against hepatitis B.
    Van Damme P; Banatvala JE
    BMJ; 2003 Jan; 326(7380):105. PubMed ID: 12521983
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Rodríguez Lay LLA; Bello Corredor M; Montalvo Villalba MC; Chibás Ojeda AG; Sariego Frómeta S; Diaz González M; Abad Lamoth Y; Sánchez Wong M; Sausy A; Muller CP; Hübschen JM
    Arch Virol; 2017 Aug; 162(8):2393-2396. PubMed ID: 28439708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Cheah BC; Davies J; Singh GR; Wood N; Jackson K; Littlejohn M; Davison B; McIntyre P; Locarnini S; Davis JS; Tong SYC
    Vaccine; 2018 Jun; 36(24):3533-3540. PubMed ID: 29735323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.
    Bialek SR; Helgenberger L; Fischer GE; Bower WA; Konelios M; Chaine JP; Armstrong G; Williams IT; Bell BP
    Pediatr Infect Dis J; 2010 Jan; 29(1):18-22. PubMed ID: 19841605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.
    Mutwa PR; Boer KR; Rusine JB; Muganga N; Tuyishimire D; Reiss P; Lange JM; Geelen SP
    Pediatr Infect Dis J; 2013 Mar; 32(3):246-51. PubMed ID: 22976050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S; Jack A; Bah E; Montesano R
    Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.